Information: NIBIO 2023 Achievement Nov. 1, 2023 Production of "Epitope region-bridging biparatopic antibody" -Improving the functionality of TNFR2 antagonist through 1:1 binding design- Achievement Jun. 28, 2023 Elucidation of the Mode of Action of Novel Universal Influenza Vaccine Candidates Achievement Feb. 28, 2023 Anti-IL-8 antibody, Improves Inflammation and Fibrosis in Endometriosis in an Industry-Government-Academia Non-Clinical Study Published in Science Translational Medicine
